This topic contains a solution. Click here to go to the answer

Author Question: What is the difference between primary and secondary volcanic hazards? What will be an ideal ... (Read 93 times)

panfilo

  • Hero Member
  • *****
  • Posts: 572
What is the difference between primary and secondary volcanic hazards? What will be an ideal response?

Question 2

What is VEI? What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

medine

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

Primary volcanic hazards are those related directly to the exit of magma from an erupting vent and the
distribution of volcanic materials across the surrounding countryside. These include hazards related to
lava flows, volcanic gases, ash and pumice falls, and PDCs. Secondary hazards are not from direct
discharge of material from a vent, but are from later effects of eruptions. These include tsunami, lahars
(volcanic debris flows), long-term volcanic degassing, and severe weather conditions



Answer to Question 2

VEI stands for Volcanic Explosivity Index. It has values that range from 0 to 10 and is based on the
volume of material ejected, the height that the material rises, whether volcanic gases and ash penetrate
the stratosphere and how long the eruption lasts.





medine

  • Sr. Member
  • ****
  • Posts: 344

 

Did you know?

Pope Sylvester II tried to introduce Arabic numbers into Europe between the years 999 and 1003, but their use did not catch on for a few more centuries, and Roman numerals continued to be the primary number system.

Did you know?

Asthma cases in Americans are about 75% higher today than they were in 1980.

Did you know?

To prove that stomach ulcers were caused by bacteria and not by stress, a researcher consumed an entire laboratory beaker full of bacterial culture. After this, he did indeed develop stomach ulcers, and won the Nobel Prize for his discovery.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

For a complete list of videos, visit our video library